Mood:
![](https://ly.lygo.net/af/d/blog/common/econ/hmmm.gif)
HER2 (human epidermal growth factor receptor 2) is present in 15%–25% of breast cancers. Women with HER2-positive breast cancer usually have more aggressive cancer, are at increased risk of recurrence and have a poorer survival than other women with breast cancer.
So I am not ER +ve, so no Tomaxifin, no Menopause. But the bad news is I am Her2 +ve as above. I have known that for a few days, but now that I've looked for more info on the internet, I am a little worried. No more internet! Arrghhh!
Posted by shelleyschulte
at 6:24 PM EDT